These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34093945)

  • 41. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p.
    Wu C; Yang J; Lin X; Wu J; Yang C; Chen S
    J Cancer; 2024; 15(6):1718-1730. PubMed ID: 38370382
    [No Abstract]   [Full Text] [Related]  

  • 43. NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2.
    Ding N; Wu H; Tao T; Peng E
    Onco Targets Ther; 2017; 10():4905-4915. PubMed ID: 29062236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA FOXD2-AS1 promotes proliferation, migration and invasion of ovarian cancer cells via regulating the expression of miR-4492.
    Gao J; Liu F; Zhao X; Zhang P
    Exp Ther Med; 2021 Apr; 21(4):307. PubMed ID: 33717250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA TMPO-AS1 serves as a tumor promoter in pancreatic carcinoma by regulating miR-383-5p/SOX11.
    Xue F; Song X; Zhang S; Niu M; Cui Y; Wang Y; Zhao T
    Oncol Lett; 2021 Apr; 21(4):255. PubMed ID: 33664819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
    Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
    Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
    You Q; Shi HY; Gong CF; Tian XY; Li S
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6429-6435. PubMed ID: 31378881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VPS9D1-AS1, a novel long-non-coding RNA, acts as a tumor promoter by regulating the miR-324-5p/ITGA2 axis in colon adenocarcinoma.
    Huang G; Yang Y; Lv M; Huang T; Zhan X; Kang W; Hou J
    Am J Transl Res; 2022; 14(2):955-966. PubMed ID: 35273698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis.
    Wang J; Zha J; Wang X
    Oncol Lett; 2021 Nov; 22(5):798. PubMed ID: 34630705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells.
    Liu Z; Hu K; Wang X; Zhang Y; Wang W; Wu Y
    Open Med (Wars); 2022; 17(1):266-279. PubMed ID: 35274046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
    Luo JF; Xu J; Zheng JZ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
    Liu R; Wang X; Yan Q
    Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway.
    Du Z; Wang L; Xia Y
    Cancer Cell Int; 2020 Nov; 20(1):572. PubMed ID: 33292255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p.
    Sun Q; Li Q; Xie F
    Onco Targets Ther; 2019; 12():6297-6307. PubMed ID: 31496733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.